10 CFR § 26.123 - Testing facility capabilities.

---
identifier: "/us/cfr/t10/s26.123"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "10 CFR § 26.123 - Testing facility capabilities."
title_number: 10
title_name: "Energy"
section_number: "26.123"
section_name: "Testing facility capabilities."
chapter_name: "NUCLEAR REGULATORY COMMISSION"
part_number: "26"
part_name: "FITNESS FOR DUTY PROGRAMS"
positive_law: false
currency: "2026-04-05"
last_updated: "2026-04-05"
format_version: "1.1.0"
generator: "[email protected]"
authority: "Atomic Energy Act of 1954, secs. 53, 103, 104, 107, 161, 223, 234, 1701 (42 U.S.C. 2073, 2133, 2134, 2137, 2201, 2273, 2282, 2297f); Energy Reorganization Act of 1974, secs. 201, 202 (42 U.S.C. 5841, 5842); 44 U.S.C. 3504 note."
regulatory_source: "73 FR 17176, Mar. 31, 2008, unless otherwise noted."
cfr_part: "26"
---


# 26.123 Testing facility capabilities.

Each licensee testing facility shall have the capability, at the same premises, to perform either validity screening tests or initial validity tests or both, and initial drug tests for each drug and drug metabolite for which testing is conducted.